Tuesday, 24 April 2018
Activities of the Pharmacovigilance & Clinical Trials are:
*To approve and monitor all clinical trials medicines and medical devices that are conducted in Zimbabwe in terms of Part III of the Medicines and Allied Substances Control Act of 1991 [Chapter 15:03].
*To deal with medicine's post-registration issues. This means that after medicines have been registered by the Authority, any issues to do with the review of those medicines fall under this unit, including the processing of applications for amendments for registered medicines.
*To approve and monitor all clinical trials involving medicines and medical devices that are conducted in Zimbabwe in terms of Part III of the Medicines and Allied Substances Control Act of 1991 [Chapter 15:03]
*To conduct Pharmacovigilance activities which include: post-market surveillance of registered medicines; collecting and analysing Adverse Drug reports;
*Drug information dissemination through publishing a quarterly drug information bulletin.
Increased Reporting from the Targeted Spontaneous Reporting (TSR) Programme Click here to download Drug Information Bulletin
Download Complementary medicines applications extension - press statement
The aims of the PV policy handbook are to firstly provide a framework for a national pharmacovigilance system in Zimbabwe. Secondly, to define the pharmacovigilance activities undertaken by the Pharmacovigilance...
The MCAZ offers training services for new and seasoned regulators from national medicines regulatory authorities (NMRAs), regulatory affairs personnel from the pharmaceutical industry, and people from academia. The course is...
The Medicines Control Authority of Zimbabwe (MCAZ) as a responsible corporate citizen runs a Scholarship Fund as part of its corporate social responsibility programmes. Click here to download the...
The approved Guidelines for Advertising and Promotion of Medicines are now available. Download the Guidelines for Advertising and Promotion of Medicines
The Medicines Control Authority of Zimbabwe is responsible for the evaluation of safety, efficacy and quality and registration of complementary medicines destined for use in Zimbabwe. Please see the documents...
Click here for more information on implementation of VAT Click here for Tax Clearance Certificate (ITF263)
The MCAZ Chemistry and Medical Devices laboratories are now accredited to the ISO/IEC 17025 standard through the Southern African Development Community Accreditation Service (SADCAS). The Chemistry laboratory is accredited for...
The ZAZIBONA process is a collaboration between national medicines regulatory authorities (NMRAs) in Botswana, Namibia, Zambia, and Zimbabwe. These are four neighbouring countries in Southern Africa which have a...